Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 625 of 1631 entries
View as:

BETAEVAL Global - The New BETACONNECT Auto-injector : Adherence and EVALuation of Multiple Sclerosis Patients Treated With Betaferon

Phase: N/A Priority: Normal
NCT ID: NCT02247310 Org: User:
Start: 10/20/14 End: 11/08/16 Due: 11/08/17

Combined Single / Multiple Dose Escalation Study in Patients With Renal Anemia Due to CKD (Chronic Kidney Disease)

Phase: N/A Priority: Normal
NCT ID: NCT01332942 Org: User:
Start: 04/30/11 End: 12/31/13 Due: 12/31/14

Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular Prophylaxis

Phase: N/A Priority: Normal
NCT ID: NCT02263066 Org: User:
Start: 10/31/14 End: 07/31/15 Due: 07/31/16

Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-remitting Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00235989 Org: User:
Start: 06/30/03 End: 01/31/08 Due: 01/31/09

A Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine Studies

Phase: N/A Priority: Normal
NCT ID: NCT03926143 Org: User:
Start: 06/03/19 End: 05/18/22 Due: 05/18/23

A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02085148 Org: User:
Start: 04/11/14 End: 03/13/24 Due: 03/13/25

Inhibition of Ovulation, Patch, Ethinylestradiol and Gestodene

Phase: N/A Priority: Normal
NCT ID: NCT00729404 Org: User:
Start: 08/31/08 End: 02/28/09 Due: 02/28/10

Effects of Phenylephrine Extended-Release Tablets on Allergy-Related Nasal Congestion (P08498 AM1)

Phase: N/A Priority: Normal
NCT ID: NCT01413958 Org: User:
Start: 08/31/11 End: 10/31/11 Due: 10/31/12

Safety and Efficacy of Oral BAY85-8501 in Patients With Non-CF (Cystic Fibrosis) Bronchiectasis

Phase: N/A Priority: Normal
NCT ID: NCT01818544 Org: User:
Start: 04/30/13 End: 06/30/14 Due: 06/30/15

A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02576431 Org: User:
Start: 09/30/15 End: 10/31/25 Due: 10/31/26

EU/LA Pearl Index Study - Transdermal Contraceptive Patch

Phase: N/A Priority: Normal
NCT ID: NCT00914693 Org: User:
Start: 04/30/09 End: 09/30/11 Due: 09/30/12

BAY86-5046 (Betaseron), Non Interventional Studies

Phase: N/A Priority: Normal
NCT ID: NCT02121444 Org: User:
Start: 06/23/14 End: 06/01/16 Due: 06/01/17

First in Human Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1214784

Phase: N/A Priority: Normal
NCT ID: NCT02212080 Org: User:
Start: 09/30/14 End: 03/31/15 Due: 03/31/16

Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension

Phase: N/A Priority: Normal
NCT ID: NCT00420342 Org: User:
Start: 01/31/07 End: 09/30/08 Due: 09/30/09

A Swedish Questionnaire Study to Investigate the Perception of Menstrual Bleedings

Phase: N/A Priority: Normal
NCT ID: NCT01643304 Org: User:
Start: 05/31/12 End: 06/30/12 Due: 06/30/13

18519 - Sun Protection Factor Assay

Phase: N/A Priority: Normal
NCT ID: NCT02776852 Org: User:
Start: 08/19/15 End: 08/28/15 Due: 08/28/16

Study to Learn About Relapse Prevention of Hypericumextract (a Drug Based on the Plant St. John Wort) in Outpatients Suffering From Moderate Depressive Episodes

Phase: N/A Priority: Normal
NCT ID: NCT04315597 Org: User:
Start: 03/03/09 End: 11/22/11 Due: 11/22/12

Regulatory Post Marketing Surveillance Study in Korea

Phase: N/A Priority: Normal
NCT ID: NCT01788722 Org: User:
Start: 07/19/13 End: 08/11/17 Due: 08/11/18

Phase I Dose Escalation Study of BAY 1163877 (Rogaratinib) in Japanese Subjects With Refractory, Locally Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02592785 Org: User:
Start: 12/15/15 End: 12/06/17 Due: 12/06/18

Study to Assess Bioequivalence of 30 and 120 mg Nifurtimox Tablets in Chronic Chagas' Patients

Phase: N/A Priority: Normal
NCT ID: NCT01927224 Org: User:
Start: 11/30/13 End: 09/30/14 Due: 09/30/15

An Observational Study, Called RegoFlex EU, to Learn More About the Use of Stivarga at Reduced Doses as Recommended (Flexible Dosing) to Treat People With Metastatic Colorectal Cancer in Real World Settings in Europe

Phase: N/A Priority: Normal
NCT ID: NCT05551039 Org: User:
Start: 08/15/22 End: 01/15/23 Due: 01/15/24

A Study Reviewing Medical Records to Learn More About Treat-and-extend With Eylea in Patients With Neovascular Age-related Macular Degeneration (nAMD).

Phase: N/A Priority: Normal
NCT ID: NCT04641234 Org: User:
Start: 12/11/20 End: 06/09/21 Due: 06/09/22

Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Capsules

Phase: N/A Priority: Normal
NCT ID: NCT01073553 Org: User:
Start: 10/31/09 End: 10/31/09 Due: 10/31/10

Evaluation of a Gel Sunscreen in Controlled Use Conditions (208/2016)

Phase: N/A Priority: Normal
NCT ID: NCT03012347 Org: User:
Start: 01/05/17 End: 01/19/17 Due: 01/19/18

Bioavailability, Food Effect and Safety, Tolerability of a New Oral Suspension in Comparison to the Marketed Moxifloxacin Tablet in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01073891 Org: User:
Start: 05/31/10 End: 01/31/11 Due: 01/31/12